“…Cells were serum-starved for 24 h in DMEM before drug treatment, to switch the cell phenotype from proliferating to contractile [ 29 ]. Treatment with 1 μM Ang II for 12 h has been found to significantly promote VSMC proliferation and migration, which are indicators of vascular remodeling and are thought to be the main causes of hypertension [ 30 ]; hence, 1 μM Ang II (G-CLONE, Beijing, China) was administered to HUASMCs for 12 h. In accordance with an earlier study [ 15 ], we pretreated cells with 30 μM propofol (Kelun, Sichuang, China) to explore the changes in VSMCs in patients with hypertension and with propofol administration at the early stage of anesthesia induction. In addition, cells were treated with an intracellular calcium chelator (BAPTA-AM, 10 μM, APExBIO, Houston, USA), the specific Cx43 gap junction agonist retinoic acid (RA, 1 μM, MedChemExpress, New Jersey, USA) [ 31 ], a specific Cx43 gap junction blocker (Gap26, 0.25 mg/ml, APExBIO, Houston, USA), and a selective RhoA inhibitor (50 μM, Rhosin hydrochloride, APExBIO).…”